多系統萎縮症の治療におけるTAK-341の研究

基本情報

NCT ID

NCT05526391

ステータス

完了

試験のフェーズ

第2相

試験タイプ

介入

目標被験者数

159

治験依頼者名

Takeda

概要

The main aim is to see how TAK-341 works after 52 weeks in participants with multiple system atrophy as measured by the Unified Multiple System Atrophy Rating Scale Part I (UMSARS). The study will enroll approximately 138 patients. Participants will receive a total of 13 intravenous infusions every 4 weeks approximately, these may be either of TAK-341 or placebo, after each infusion some blood samplings will be taken and other assessments completed. This trial will be conducted in North America, Europe and Asia.

対象疾患

介入

依頼者（Sponsor）

実施施設 (6)